These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 35182988)
1. Deactivation of AKT/GSK-3β-mediated Wnt/β-catenin pathway by silencing of KIF26B weakens the malignant behaviors of non-small cell lung cancer. Chen N; Wu Q; Zhang G; Fu J; Geng Q; Zhang Y Tissue Cell; 2022 Jun; 76():101750. PubMed ID: 35182988 [TBL] [Abstract][Full Text] [Related]
2. Identification of Li Q; Zhan X; Tan Y Discov Med; 2024 Jun; 36(185):1280-1288. PubMed ID: 38926114 [TBL] [Abstract][Full Text] [Related]
3. SKA3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt/β-catenin signaling via modulation of the Akt/GSK-3β axis. Li C; Yang J; Lei S; Wang W Brain Res; 2021 Aug; 1765():147500. PubMed ID: 33895155 [TBL] [Abstract][Full Text] [Related]
4. FAM84B acts as a tumor promoter in human glioma via affecting the Akt/GSK-3β/β-catenin pathway. Wang M; Li C; Shi W Biofactors; 2021 Jul; 47(4):600-611. PubMed ID: 33759248 [TBL] [Abstract][Full Text] [Related]
5. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer. Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915 [TBL] [Abstract][Full Text] [Related]
6. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway. Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361 [TBL] [Abstract][Full Text] [Related]
7. Silencing of KIF18B restricts proliferation and invasion and enhances the chemosensitivity of breast cancer via modulating Akt/GSK-3β/β-catenin pathway. Jiang J; Liu T; He X; Ma W; Wang J; Zhou Q; Li M; Yu S Biofactors; 2021 Sep; 47(5):754-767. PubMed ID: 34058791 [TBL] [Abstract][Full Text] [Related]
8. TMED3 exerts a protumor function in non-small cell lung cancer by enhancing the Wnt/β-catenin pathway via regulation of AKT. Zhang D; Sun L; Zhang J Toxicol Appl Pharmacol; 2021 Dec; 433():115793. PubMed ID: 34758370 [TBL] [Abstract][Full Text] [Related]
9. KIF2C accelerates the development of non-small cell lung cancer and is suppressed by miR-186-3p via the AKT-GSK3β-β-catenin pathway. Guo J; Zhang W; Sun L; Yu H; Wang Y; Feng L; Yang H Sci Rep; 2023 May; 13(1):7288. PubMed ID: 37142638 [TBL] [Abstract][Full Text] [Related]
10. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway. Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974 [TBL] [Abstract][Full Text] [Related]
11. CDK5RAP3 acts as a putative tumor inhibitor in papillary thyroid carcinoma via modulation of Akt/GSK-3β/Wnt/β-catenin signaling. Feng X; Jiang J; Sun L; Zhou Q Toxicol Appl Pharmacol; 2022 Apr; 440():115940. PubMed ID: 35219640 [TBL] [Abstract][Full Text] [Related]
12. AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation. Tang Z; Yang G; Wang X; Chen F; Liao Z; Zhang Z; Liu Z; Zeng W; Fang M; Wang W; Sun X; Huo G J Neurooncol; 2020 Sep; 149(2):231-242. PubMed ID: 32909117 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of DDX46 suppresses the proliferation and invasion of gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway. Chen L; Xu M; Zhong W; Hu Y; Wang G Exp Cell Res; 2021 Feb; 399(1):112448. PubMed ID: 33347858 [TBL] [Abstract][Full Text] [Related]
14. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma. Chen Q; Zheng PS; Yang WT Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879 [TBL] [Abstract][Full Text] [Related]
15. Nucleolar and spindle-associated protein 1 accelerates cellular proliferation and invasion in nasopharyngeal carcinoma by potentiating Wnt/β-catenin signaling via modulation of GSK-3β. Zhang L; Dang Y; Wang Y; Fan X J Bioenerg Biomembr; 2020 Dec; 52(6):441-451. PubMed ID: 33196964 [TBL] [Abstract][Full Text] [Related]
16. Silencing of Nudix type 5 represses proliferation and invasion and enhances chemosensitivity of gastric carcinoma cells by affecting the AKT/GSK-3β/β-catenin pathway. Tan D; Zhang Y Toxicol Appl Pharmacol; 2022 Apr; 441():115968. PubMed ID: 35247377 [TBL] [Abstract][Full Text] [Related]
17. Spindle and kinetochore‑associated complex subunit 3 accelerates breast cancer cell proliferation and invasion through the regulation of Akt/Wnt/β-catenin signaling. Zhang J; Liu Y; Pu S; He J; Zhou C Breast Cancer Res Treat; 2021 Feb; 186(1):247-258. PubMed ID: 33423159 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer. Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281 [TBL] [Abstract][Full Text] [Related]
19. Suppression of the proliferation and invasion of breast cancer cells by ST7L occurs through inhibition of activation of Wnt/GSK-3β/β-catenin signalling. Wang H; Sun L; Jiang J; Yu S; Zhou Q Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):119-126. PubMed ID: 31429477 [TBL] [Abstract][Full Text] [Related]
20. Thongsom S; Racha S; Ei ZZ; Petsri K; Aksorn N; Chamni S; Panpuang V; Zou H; Chanvorachote P Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]